CH
Collins Helen Louise
OFFICER
€455,006
▼ Sales (12 ops.)
Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Collins Helen Louise. Officer active across 1 company, notably Enliven Therapeutics, Inc.. In total, 22 filings have been logged. Split: 0 buy · 12 sells. Total volume traded: €455k. History available since 11 April 2024. The latest transaction was filed on 17 July 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Collins Helen Louise
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
5,000 shares@ US$2.48Common StockSEC:0001701247-26-000011:0
231 shares@ US$50.0542Common StockSEC:0001701247-26-000011:1
459 shares@ US$51.5466Common StockSEC:0001701247-26-000011:2
2,063 shares@ US$52.3921Common StockSEC:0001701247-26-000011:3
2,184 shares@ US$53.4199Common StockSEC:0001701247-26-000011:4
63 shares@ US$53.9208Common StockSEC:0001701247-26-000011:5
5,000 sharesCommon StockSEC:0001701247-26-000010:0
1,268 sharesCommon StockSEC:0001701247-26-000010:1
2,599 sharesCommon StockSEC:0001701247-26-000010:2
1,133 sharesCommon StockSEC:0001701247-26-000010:3
5,000 shares@ US$2.480.0004% mcap3.7% of flowCommon StockSEC:0001701247-26-000006:0
140 shares@ US$45.81070.0002% mcap1.9% of flowCommon StockSEC:0001701247-26-000006:1
2,419 shares@ US$47.38960.0039% mcap34.3% of flowCommon StockSEC:0001701247-26-000006:2
2,441 shares@ US$48.05550.0040% mcap35.1% of flowCommon StockSEC:0001701247-26-000006:3
40,000 shares@ US$2.4823.2% of flowCommon StockSEC:0001701247-26-000005:0
5,000 shares@ US$2.482.8% of flowCommon StockSEC:0001701247-26-000004:0
29,871 shares@ US$2.4811.9% of flowCommon StockSEC:0001701247-26-000003:0
45,000 shares@ US$2.4817.5% of flowCommon StockSEC:0001701247-26-000002:0
25,000 shares0Common StockSEC:0001701247-26-000001:0
816 shares@ US$2.480.7% of flowCommon StockSEC:0001415889-24-025499:0
816 shares@ US$30.0038.0% of flowCommon StockSEC:0001415889-24-025499:1
20,000 shares@ US$2.4816.3% of flowCommon StockSEC:0001415889-24-010823:0
About Collins Helen Louise
Collins Helen Louise is a declarant linked to Enliven Therapeutics, Inc., where the listed role is CHIEF MEDICAL OFFICER. She has 11 filings in total, and across the 11 sampled filings the recorded activity runs from 2024-04-15 to 2026-06-22, with 224897 in sales and a modal transaction nature listed as Sale.